FDA recall Z-1946-2018

Siemens Healthcare Diagnostics, Inc. · Class II · device

Product

Syva¿ EMIT¿ 2000 Theophylline Product Usage: The Syva¿ Emit¿ 2000 Theophylline Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of theophylline in human serum or plasma.

Reason for recall

Lot J1 of the Syva¿ EMIT¿ 2000 Theophylline Assay, when run on a Beckman AU Clinical Chemistry System, may exhibit increased imprecision for commercially available controls and for patient samples.

Distribution

US Nationwide Distribution

Key facts

Status
Terminated
Initiation date
2017-11-27
Report date
2018-06-06
Termination date
2019-04-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
Newark, DE, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1946-2018